EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties.
Rumona DicksonAngela BolandRui V DuarteEleanor KotasNerys WoolacottRobert HodgsonRob RiemsmaSabine GrimmBram RamaekersManuela JooreNasuh BüyükkaramikliEva KaltenthalerMatt StevensonAbdullah PandorSteve EdwardsMartin HoyleJonathan ShepherdXavier ArmoiryMiriam BrazzelliPublished in: Applied health economics and health policy (2019)